Nattokinase Market Size & Growth Forecast 2027–2036, By Segments (Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to content
Market Size and Growth Outlook
Nattokinase Market size was over USD 35.2 billion in 2026 and is likely to grow at a 3.04% CAGR between 2027 and 2036, surpassing USD 47.49 billion by 2036. The industry revenue for 2027 is assessed at USD 36.1 billion.
Get more details on this report
Request Free Sample ReportNattokinase Market Intelligence Snapshot
Regional Market Dynamics
- Asia Pacific led the market in 2026 due to strong familiarity with fermented soy products, a robust manufacturing base, and steady demand for enzyme-based wellness products.
- North America is projected to grow at a 3.65% CAGR, supported by rising interest in preventive health, broader supplement adoption, and expanding retail and e-commerce availability.
Segment Momentum
- Nutraceuticals lead with 47.91% share due to strong consumer demand for daily cardiovascular wellness supplements and wide availability in capsule and tablet formulations for routine use.
- Pharmaceuticals are growing fastest due to rising interest in clinically positioned cardiovascular treatments and structured medical use cases beyond general wellness supplementation.
Market Expansion Drivers
- Rising cardiovascular health awareness increasing demand for natural fibrinolytic dietary supplements.
- Growing consumer preference for natural functional ingredients accelerating supplement market penetration.
- Expanding use of nattokinase in functional foods and skincare formulations broadening commercial applications.
Leading Market Participants
- Leading companies in the nattokinase market include Japan Bio Science Laboratory Co., Ltd. (Japan), Novonesis A/S (Denmark), BIO-CAT, Inc. (U.S.), Creative Enzymes (U.S.), Daiwa Pharmaceutical Co., Ltd. (Japan), Contek Life Science Co., Ltd. (China), Sungen Bioscience Co., Ltd. (Taiwan), Weidan Biotechnology Co., Ltd. (China), Bioven Ingredients (Spain), Eiffel Biotech Co., Ltd. (China).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 35.2 billion
- 2027 Estimated Market Size: USD 36.1 billion.
- Projected Market Size: USD 47.49 billion by 2036
- Growth Forecast: 3.04% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: Asia Pacific
- High-Growth Regional Hub: North America
- Core Revenue Segment: Nutraceuticals (Application)
- Emerging Opportunity Segment: Pharmaceuticals (Application)
Market Growth Drivers and Industry Trends
Rising cardiovascular health awareness increasing demand for natural fibrinolytic dietary supplements
Growing awareness of cardiovascular health is encouraging consumers to seek dietary supplements associated with cardiovascular wellness and natural fibrinolytic support. This trend will drive the nattokinase market as greater attention to preventive health increases interest in natural ingredients used in cardiovascular-focused supplementation. Consumers seeking functional approaches to health management are contributing to demand for supplements positioned around targeted wellness needs.
Growing consumer preference for natural functional ingredients accelerating supplement market penetration
Consumer preference for natural functional ingredients is strengthening interest in supplements that combine perceived wellness benefits with naturally derived components. The nattokinase market is gaining from this shift as supplement users increasingly seek functional ingredients that align with natural product preferences. This purchasing behavior is supporting broader penetration of nattokinase-based offerings within the dietary supplement space and encouraging greater consideration of functional ingredient formulations.
Expanding use of nattokinase in functional foods and skincare formulations broadening commercial applications
The incorporation of nattokinase into functional foods and skincare formulations is broadening its commercial use beyond conventional dietary supplementation. Expanding applications will propel the nattokinase market by creating additional product formats and increasing opportunities for manufacturers to incorporate the ingredient into consumer-oriented formulations. Its use across different categories is widening the range of potential applications and supporting greater market exposure through diversified product offerings.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising cardiovascular health awareness increasing demand for natural fibrinolytic dietary supplements | 1.80% | Moderate | North America, Asia Pacific | High | Near Term |
| Growing consumer preference for natural functional ingredients accelerating supplement market penetration | 1.60% | Low | Europe, North America | High | Near Term |
| Expanding use of nattokinase in functional foods and skincare formulations broadening commercial applications | 1.20% | Moderate | Asia Pacific, Europe | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
Asia Pacific (Largest Region)
Holding the largest share of the nattokinase market in 2026, Asia Pacific benefits from strong consumer familiarity with fermented foods and traditional wellness practices, particularly those associated with cardiovascular health and natural nutritional products. The region has a well-established foundation for functional foods and dietary supplements, creating favorable conditions for nattokinase-based products. Rising health awareness, expanding preventive healthcare practices, and growing consumer interest in plant- and food-derived wellness solutions are supporting demand. The development of modern nutraceutical formulations and broader retail and digital distribution channels is also helping manufacturers reach increasingly health-conscious consumers.
North America (Fastest-Growing Region)
North America is the fastest-growing region, propelled by increasing interest in preventive wellness, dietary supplements, and functional ingredients with cardiovascular health applications. Consumers are becoming more attentive to products positioned around healthy aging, circulatory wellness, and proactive health management, creating opportunities for nattokinase in the broader nutraceutical sector. Expanding availability through specialized nutrition outlets and online channels is improving product accessibility, while continued innovation in supplement formulations and greater consumer awareness of naturally derived ingredients are supporting market expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
Germany 🇩🇪
Evidence-Based SupplementsGermany places strong emphasis on ingredient quality, product transparency, and scientifically supported health supplements. Companies in Germany increasingly position nattokinase products within premium wellness portfolios targeting cardiovascular health awareness.
France 🇫🇷
Premium Nutraceutical FocusFrance emphasizes premium dietary supplements supported by quality standards and consumer confidence in natural wellness products. Nattokinase suppliers in France increasingly differentiate products through ingredient sourcing and clinically informed positioning.
Italy 🇮🇹
Natural Health FormulationsItaly shows growing interest in nattokinase products that complement preventive health and balanced lifestyle approaches. Supplement manufacturers in Italy prioritize natural formulations and product differentiation to meet evolving consumer wellness preferences.
Japan 🇯🇵
Traditional Functional NutritionJapan maintains steady demand for nattokinase through its long-standing association with fermented food traditions and functional nutrition. Manufacturers in Japan continue refining high-quality formulations while supporting innovation in health-focused supplement products.
South Korea 🇰🇷
Functional Ingredient InnovationSouth Korea expands nattokinase applications through innovation in dietary supplements and functional health products. Companies in South Korea increasingly develop convenient formulations that appeal to consumers seeking preventive cardiovascular wellness solutions.
United States 🇺🇸
Preventive Wellness DemandThe U.S. nattokinase market benefits from growing consumer interest in cardiovascular wellness and functional dietary supplements. Manufacturers in the U.S. focus on product quality, scientific positioning, and diversified supplement formulations for health-conscious consumers.
Nattokinase Market Share (%), by Application, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportApplication Segment Analysis: Nutraceuticals (Largest Segment) vs Pharmaceuticals (Fastest-Growing Segment)
The nutraceuticals segment led the nattokinase market, accounting for a 47.91% share in 2026, supported by growing consumer interest in functional ingredients positioned around cardiovascular wellness and preventive health. Nattokinase is increasingly incorporated into nutraceutical formulations because of its natural origin and suitability for health-focused products. Demand is further supported by expanding awareness of dietary approaches to wellness and the preference for convenient supplement formats, allowing nutraceutical applications to maintain a strong position across the market.
Pharmaceutical applications are gaining momentum as interest increases in the potential therapeutic use of nattokinase and its functional properties. Greater attention to evidence-based applications, formulation development, and the integration of bioactive compounds into healthcare-oriented products is creating opportunities for pharmaceutical adoption. This shift toward more targeted and clinically relevant applications is strengthening demand for nattokinase beyond traditional dietary supplement use.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Application | Nutraceuticals, Food Additives, Pharmaceuticals, Others | Nutraceuticals | Pharmaceuticals |
Competitive Landscape and Market Positioning
Major players in the nattokinase market:
1. Japan Bio Science Laboratory Co. Ltd. (Japan)
2. Novonesis A/S (Denmark)
3. BIO-CAT Inc. (U.S.)
4. Creative Enzymes (U.S.)
5. Daiwa Pharmaceutical Co. Ltd. (Japan)
6. Contek Life Science Co. Ltd. (China)
7. Sungen Bioscience Co. Ltd. (Taiwan)
8. Weidan Biotechnology Co. Ltd. (China)
9. Bioven Ingredients (Spain)
10. Eiffel Biotech Co. Ltd. (China)
Rising interest in enzyme-based health supplements is driving formulation diversification in functional nutrition products. The nattokinase market is evolving as research explores broader cardiovascular and wellness applications. Continuous innovation in extraction and stabilization methods is enhancing product effectiveness and consumer adoption.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Japan Bio Science Laboratory Co. Ltd. (Japan) | |||||||
| Novonesis A/S (Denmark) | |||||||
| BIO-CAT Inc. (U.S.) | |||||||
| Creative Enzymes (U.S.) | |||||||
| Daiwa Pharmaceutical Co. Ltd. (Japan) | |||||||
| Contek Life Science Co. Ltd. (China) | |||||||
| Sungen Bioscience Co. Ltd. (Taiwan) | |||||||
| Weidan Biotechnology Co. Ltd. (China) | |||||||
| Bioven Ingredients (Spain) | |||||||
| Eiffel Biotech Co. Ltd. (China). |
Industry Development / News
| Company Name | Date | Key Development |
|---|---|---|
| JBSL | Apr-26 | JBSL secured a patent for its NSK-SD nattokinase ingredient, reinforcing its intellectual property position in functional enzyme-based health solutions. Supported by emerging studies on blood sugar regulation and inflammation reduction, the patent strengthens commercialization prospects and enhances differentiation within the competitive nutraceutical and cardiovascular wellness ingredient market. |
| Japan Bio Science Laboratory CO., Ltd. | Sep-24 | Japan Bio Science Laboratory unveiled its NSK-SD nattokinase enzyme at SupplySide West, highlighting its patented and clinically studied formulation. The introduction reinforces its positioning in the functional health ingredient market and supports commercialization efforts for enzyme-based nutraceutical applications targeting cardiovascular wellness. |
| Kirin Holdings | Aug-24 | Kirin Holdings and Takanofoods launched a new fermented soybean natto product incorporating Lactococcus lactis strain Plasma, aimed at supporting immune function. The product expansion reflects continued innovation in functional fermented foods, reinforcing competitive activity in health-oriented food formulations linked to cardiovascular and metabolic wellness trends. |
| Daiken Biomedical | Feb-24 | Daiken Biomedical utilized a Japan-based patent for its triple-action health formula as part of its growth strategy. The company leverages intellectual property protection to reinforce product credibility and consumer trust, supporting expansion efforts in functional health and nutraceutical markets where differentiation and scientific validation are key competitive drivers. |
| Gnosis by Lesaffre | May-21 | Gnosis by Lesaffre acquired NattoPharma, expanding its portfolio in vitamin K2 and natto-derived health ingredients. The acquisition strengthens its position in cardiovascular and bone health nutrition segments by integrating complementary functional ingredients and broadening its ability to serve global nutraceutical markets with a more comprehensive product offering. |
| Compagnie Des Levures Lesaffre | May-21 | Compagnie Des Levures Lesaffre completed the acquisition of the remaining 23% stake in NattoPharma ASA, consolidating full ownership of the biotechnology company. The transaction strengthens Lesaffre’s control over natto-derived bioactive ingredient development and supports strategic expansion in functional health and nutraceutical ingredient markets. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Nattokinase Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Source | Traditional Fermentation-Derived, Microbial Fermentation-Derived, Enzyme-Enhanced Fermentation |
| Form | Capsules & Tablets, Powders, Liquid Formulations, Functional Food & Beverage Formats |
| Distribution Channel | Pharmacies & Drugstores, Online Retail, Supermarkets & Health Food Stores, Direct Sales |
Nattokinase Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Functional Health Ingredient Adoption Analysis |
|
| Consumer Wellness Trend Assessment |
|
| Regulatory and Market Access Landscape |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the market valuation of nattokinase?
What is the projected value of the nattokinase industry by 2036?
How is rising cardiovascular health awareness influencing consumer demand in the nattokinase market?
How are natural ingredient preferences and cross-category applications expanding market opportunities for nattokinase?
Why does Nutraceuticals dominate the nattokinase market?
Why is Pharmaceuticals the fastest-growing application in the nattokinase market?
Why does Asia Pacific dominate the nattokinase market?
Why is North America the fastest-growing nattokinase market?
Which companies dominate the nattokinase landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook